On May 31, 2019 Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, reported that it will present at the following upcoming investor conferences (Press release, Ultragenyx Pharmaceutical, MAY 31, 2019, View Source [SID1234536730]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Shalini Sharp, the company’s Chief Financial Officer, will present at the Jefferies Healthcare Conference on Tuesday, June 4, 2019 at 8:00 a.m. ET in New York, NY.

Emil D. Kakkis, M.D., Ph.D., the company’s Chief Executive Officer, President and Founder, will present at the Goldman Sachs 40TH Annual Global Healthcare Conference on Thursday, June 13, 2019 at 9:20 a.m. PT in Palos Verdes, CA.
The live and archived webcast of the company presentations will be accessible from the company’s website at View Source The replay of the webcast will be available for 90 days.